
Masimo Corporation
- Jurisdiction
United States - LEI
549300Q4A8JK0PIYCU29 - ISIN
US5747951003 (MASI )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. Read full profile
Fundamentals
- Net revenue
€1.58B - Gross margin
52.8% - EBIT
-€158.99M - EBIT margin
-10.1% - Net income
-€391.68M - Net margin
-24.8%
Statement period: - (published )
Stock price
Dividends
- Last dividend amount
-
$1.00 - Ex date
-
- Payment date
-
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Brennan Michelle | N/A |
|
|
|
|
Jellison William R | N/A |
|
|
|
|
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Sell |
Ray Dalio |
|
|
|
Sell |
Earnings Calls
Latest earnings call: May 7, 2024 (Q1 2024)